Universität zu Köln

Journal Article

Bazarbachi, Ali, Boumendil, Ariane, Finel, Herve, Mohty, Mohamad, Castagna, Luca, Blaise, Didier, Peggs, Karl S., Afanasyev, Boris, Diez-Martin, J. L., Corradini, Paolo, Michonneau, David ORCID: 0000-0003-4553-3065, Robinson, Stephen, Gutierrez Garcia, Gonzalo, Bonifazi, Francesca, Yakoub-Agha, Ibrahim, Gulbas, Zafer, Bloor, Adrian, Delage, Jeremy, Esquirol, Albert, Malladi, Ram, Scheid, Christof, El-Cheikh, Jean, Ghesquieres, Herve, Montoto, Silvia, Dreger, Peter and Sureda, Anna (2019). Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Cancer, 125 (1). S. 90 - 99. HOBOKEN: WILEY. ISSN 1097-0142

Bishop, Michael R., Dickinson, Michael, Purtill, Duncan, Barba, Pere, Santoro, Armando, Hamad, Nada, Kato, Koji, Sureda, Anna, Greil, Richard, Thieblemont, Catherine, Morschhauser, Franck, Janz, Martin, Flinn, Ian W., Rabitsch, Werner, Kwong, Yok Lam, Kersten, Marie Jose, Minnema, Monique C., Holte, Harald, Chan, Esther Hian Li, Martinez-Lopez, Joaquin, Mueller, Antonia M. S., Maziarz, Richard T., McGuirk, Joseph P., Bachy, Emmanuel, Le Gouill, Steven, Dreyling, Martin, Harigae, Hideo, Bond, David A., Andreadis, Charalambos, McSweeney, Peter A., Kharfan-Dabaja, Mohamed A., Newsome, Simon, Degtyarev, Evgeny, Del Corral, Chris, Andreola, Giovanna, Masood, Aisha, Schuster, Stephen J., Jaeger, Ulrich, Borchmann, Peter and Westin, Jason R. (2021). Tisagenlecleucel Vs Standard of Care As Second-Line Therapy of Primary Refractory or Relapsed Aggressive B-Cell Non-Hodgkin Lymphoma: Analysis of the Phase III Belinda Study. Blood, 138. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Harrison, Simon J., Hsu, Andy K., Neeson, Paul ORCID: 0000-0002-2729-5887, Younes, Anas, Sureda, Anna, Engert, Andreas, Prince, H. Miles, Li, Martha, Savage, Paula, Bugarini, Roberto, Williams, Denise, Squier, Margaret and Ritchie, David S. (2014). Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant. Leuk. Lymphoma, 55 (5). S. 1053 - 1061. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Josting, Andreas, Mueller, Horst, Borchmann, Peter, Baars, Joke W., Metzner, Bernd ORCID: 0000-0002-1496-1377, Doehner, Hartmut, Aurer, Igor, Smardova, Lenka, Fischer, Thomas, Niederwieser, Dietger, Schaefer-Eckart, Kerstin, Schmitz, Norbert, Sureda, Anna, Glossmann, Jan, Diehl, Volker, DeJong, Daphne, Hansmann, Martin-Leo, Raemaekers, John and Engert, Andreas (2010). Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma. J. Clin. Oncol., 28 (34). S. 5074 - 5081. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Martinez, Carmen, Gayoso, Jorge, Canals, Carmen, Finel, Herve, Peggs, Karl, Dominietto, Alida, Castagna, Luca, Afanasyev, Boris, Robinson, Stephen, Blaise, Didier, Corradini, Paolo, Itala-Remes, Maija, Bermudez, Arancha, Forcade, Edouard, Russo, Domenico, Potter, Michael, McQuaker, Grant, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Scheid, Christof, Bloor, Adrian, Montoto, Silvia ORCID: 0000-0002-3006-9725, Dreger, Peter and Sureda, Anna (2017). Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. J. Clin. Oncol., 35 (30). S. 3425 - 3436. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sureda, Anna, Andre, Marc, Borchmann, Peter, da Silva, Maria G., Gisselbrecht, Christian, Vassilakopoulos, Theodoros P., Zinzani, Pier Luigi and Walewski, Jan (2020). Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective. BMC Cancer, 20 (1). LONDON: BMC. ISSN 1471-2407

Sureda, Anna, Chabannon, Christian, Masszi, Tamas, Pohlreich, David, Scheid, Christof, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Wahlin, Bjorn E., Sakellari, Ioanna, Russell, Nigel, Janikova, Andrea, Dabrowska-Iwanicka, Anna, Touzeau, Cyrille, Esquirol, Albert, Jantunen, Esa, van der Werf, Steffie, Bosman, Paul, Boumendil, Ariane, Liu, Qianying, Celanovic, Marina, Montoto, Silvia and Dreger, Peter (2018). Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients with Lymphoma Receiving Plerixafor. Bone Marrow Transplant., 53. S. 599 - 601. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Sureda, Anna, Chabannon, Christian ORCID: 0000-0002-3755-4889, Masszi, Tamas, Pohlreich, David, Scheid, Christof, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Wahlin, Bjorn E., Sakellari, Ioanna, Russell, Nigel, Janikova, Andrea, Dabrowska-Iwanicka, Anna ORCID: 0000-0001-8986-0397, Touzeau, Cyrille ORCID: 0000-0003-0275-2575, Esquirol, Albert, Jantunen, Esa, van der Werf, Steffie, Bosman, Paul, Boumendil, Ariane ORCID: 0000-0002-2552-0542, Liu, Qianying, Celanovic, Marina, Montoto, Silvia and Dreger, Peter (2020). Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor. Bone Marrow Transplant., 55 (3). S. 613 - 623. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Sureda, Anna, Younes, Anas, Ben-Yehuda, Dina, Ong, Tee-Chuan, Kaufman, Jonathan L., Le Corre, Christophe, Gallagher, Jennifer, Shen, Angela and Engert, Andreas (2010). Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant. Blood, 116 (21). S. 187 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

von Tresckow, Bastian, Morschhauser, Franck, Szer, Jeffrey, Eichenauer, Dennis A., Abramson, Jeremy S., Sureda, Anna and Engert, Andreas (2017). Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuation. Leuk. Lymphoma, 58 (1). S. 222 - 226. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403